[New antihypertensive agent, DL (methylene-dioxy-3-4) phenyl 2 hydroxy-2-acetamidine hydrochloride (LL 1418). Toxicity; general properties].
D000014:Abnormalities, Drug-Induced; D000578:Amidines / Q000494:pharmacology* / Q000633:toxicity*; D014670:Ampulla of Vater / Q000187:drug effects; D000779:Anesthetics, Local; D000818:Animals; D000959:Antihypertensive Agents; D002490:Central Nervous System / Q000187:drug effects; D004232:Diuretics; D004357:Drug Synergism; D005260:Female; D006993:Hypnotics and Sedatives / Q000494:pharmacology; D008297:Male; D008620:Meprobamate / Q000494:pharmacology; D051379:Mice; D009130:Muscle, Smooth / Q000187:drug effects; D009132:Muscles; D011817:Rabbits; D051381:Rats
D000578:Amidines; D000779:Anesthetics, Local; D000959:Antihypertensive Agents; D004232:Diuretics; D006993:Hypnotics and Sedatives; D008620:Meprobamate
Nouvel anti-hypertenseur, le chlorhydrate de DL (méthylène-dioxy-3-4) phényl 2 hydroxy-2-acétamidine (LL 1418). Toxicité-propriétés générales.